Reduced prevalence of HBsAg variants following a successful immunization program in China

Affiliations

Comment

Wolfgang Jilg et al. J Virol. 2014 Apr.

. 2014 Apr;88(8):4605-6.

doi: 10.1128/JVI.03654-13.

¹ Institute for Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.

No abstract available

Comment on

Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China.
Bian T, Yan H, Shen L, Wang F, Zhang S, Cao Y, Zhang S, Zhang Y, Bi S. Bian T, et al. J Virol. 2013 Nov;87(22):12196-206. doi: 10.1128/JVI.02127-13. Epub 2013 Sep 4. J Virol. 2013. PMID: 24006443 Free PMC article.

1. Bian T, Yan H, Shen L, Wang F, Zhang S, Cao Y, Zhang S, Zhang Y, Bi S. 2013. Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China. J. Virol. 87:12196–12206. 10.1128/JVI.02127-13 - DOI - PMC - PubMed
1. American Society for Microbiology. 2013. Universal hepatitis B vaccination in China boosts breakthrough mutant viruses. Microbe 8:393–394
1. Hsu HY, Chang MY, Liaw SH, Ni YH, Chen HL. 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312–1317. 10.1002/hep.510300511 - DOI - PubMed
1. Hsu UY, Chang MH, Ni YH. 2004. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53:1499–1503. 10.1136/gut.2003.034223 - DOI - PMC - PubMed
1. Lai MW, Lin TT, Tsao KC, Huang CG, Hsiao MJ, Liang KH, Yeh CT. 2012. Increased seroprevalence of HBV DNA with mutations in the S gene among individuals greater than 18 years old after complete vaccination. Gastroenterology 143:400–407. 10.1053/j.gastro.2012.05.002 - DOI - PubMed